GlassScriptPhysician profile
Aparna Marwaha
NPI 1649954215
$952.58
in general payments reported to CMS, 2019-2025
16 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $273 · 2024: $430 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $952.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $232.05 | 2023-2025 | Repatha, Repatha |
| Novo Nordisk INC | $188.48 | 2024-2025 | Ozempic, Wegovy |
| Lexicon Pharmaceuticals, INC. | $143.90 | 2023 | Inpefa |
| Cleerly, INC. | $94.75 | 2024-2025 | Cleerly Labs, Cleerly Ischemia |
| Cvrx, INC. | $45.25 | 2023-2024 | Barostim Neo System |
| Siemens Medical Solutions USA, INC. | $32.44 | 2024 | Biograph Horizon-3r |
| Lilly USA, LLC | $30.53 | 2024 | Mounjaro, Zepbound |
| Edwards Lifesciences Corporation | $27.72 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.36 | 2023-2024 | Lifevest |
| Impulse Dynamics (USA) INC. | $27.29 | 2024 | Optimizer |
| Baxter Healthcare | $20.09 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Philips North America LLC | $18.36 | 2024 | (Ck4) Mcot |
| Scpharmaceuticals INC. | $17.82 | 2024 | |
| Viiv Healthcare Company | $16.37 | 2025 | Apretude |
| Esperion Therapeutics, INC. | $16.16 | 2023 | Nexletol |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $14.01 | 2024 | Omnipod |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aparna Marwaha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.